KRISTI FRANCIS: Open Payments
NPI 1295743672 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,987 in 97 payments from 15 companies in 2025. Trend: 2023 $1,876 · 2024 $1,867 · 2025 $1,987
Food & beverage: $1,987
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $604 |
| UCB, Inc. | 14 | $249 |
| Novartis Pharmaceuticals Corporation | 10 | $243 |
| GlaxoSmithKline, LLC. | 17 | $224 |
| Janssen Biotech, Inc. | 7 | $148 |
| Atland Pharmaceuticals, LLC | 1 | $125 |
| PFIZER INC. | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $76 |
| Organon LLC | 2 | $31 |
Products named: RINVOQ, Bimzelx, COSENTYX, BENLYSTA, SKYRIZI, TREMFYA, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, XELJANZ.
Industry payments across AL — which companies pay providers there.
